Global Cannabis Testing Market Growth (Status and Outlook) 2023-2029

Global Cannabis Testing Market Growth (Status and Outlook) 2023-2029

Cannabis testing defines various drug test methods for the usage of cannabis in medical prescription, sports medicine, and law. The rapidly increasing applications of cannabis (marijuana) in mainstream medicine such as pain management is poised to increase demand for cannabis testing measures.

LPI (LP Information)' newest research report, the “Cannabis Testing Industry Forecast” looks at past sales and reviews total world Cannabis Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Cannabis Testing sales for 2023 through 2029. With Cannabis Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cannabis Testing industry.

This Insight Report provides a comprehensive analysis of the global Cannabis Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cannabis Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cannabis Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cannabis Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cannabis Testing.

The global Cannabis Testing market size is projected to grow from US$ 897.1 million in 2022 to US$ 1418.5 million in 2029; it is expected to grow at a CAGR of 6.8% from 2023 to 2029.

The increasing use of cannabis for medical purposes is one of the major factors driving the global cannabis testing market. Cannabis used for medicinal purposes is referred to as medical marijuana or medical cannabis. In this case, the whole, unprocessed cannabis plant or its extracts are used to treat a variety of symptoms and conditions. Medical cannabis contains many compounds that are collectively referred to as cannabinoids. The two main compounds are tetrahydrocannabinol (THC) and Cannabidiol (CBD). Though there are several other types of cannabinoids in cannabis strains, THC and CBD are the most abundant compounds. These compounds mainly address pain symptoms in multiple diseases.

This report presents a comprehensive overview, market shares, and growth opportunities of Cannabis Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Terpene Profiling Testing
Heavy Metal Testing
Microbial Analysis Testing
Genetic Testing
Residual Solvent Screening Testing
Potency Testing
Pesticide Screening Testing

Segmentation by application
Laboratories
Research Institutions
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies
Shimadzu Corporation
PerkinElmer
Millipore Sigma
AB SCIEX LLC
Waters Corporation
Restek Corporation
Accelerated Technology Laboratories
LabLynx

Please note: The report will take approximately 2 business days to prepare and deliver.